Projects per year
Abstract
Background and purpose: Quality indicators (QIs) have been developed for many aspects of prostate cancer care, but are under-developed with regard to radiotherapy treatment. We aimed to develop a valid, relevant and feasible set of core QIs to measure quality of radiotherapy care in men with prostate cancer. Materials and methods: We used a RAND-modified Delphi process to select QIs that were regarded as both important and feasible measures of quality radiotherapy care. This involved two phases: (1) a literature review to identify a list of proposed QIs; and (2) a QI selection process by an expert panel (n = 12) conducted in a series of three rounds: two online questionnaires’ and one face-to-face meeting. The RAND criterion identified variation in ratings and determined the level of agreement after each round of voting. Results: A total of 144 candidate QIs, which included measures from pre-treatment to post-treatment and survivorship care were identified. After three rounds of voting, the panel approved a comprehensive set of 17 QIs, with most assessing a process of care (n = 16, 94.1%) and the remaining assessing a health outcome. Conclusion: This study developed a core set of 17 QIs which will be used to report from the Prostate Cancer Outcomes Registry-Australia & New Zealand, to monitor the quality of radiotherapy care prostate cancer patients receive.
Original language | English |
---|---|
Pages (from-to) | 308-314 |
Number of pages | 7 |
Journal | Radiotherapy and Oncology |
Volume | 128 |
Issue number | 2 |
DOIs | |
Publication status | Published - Aug 2018 |
Keywords
- Healthcare
- Prostatic neoplasms
- Quality indicators
- Quality of health care
- Radiotherapy
-
Australian Prostate Cancer Clinical Registry
Papa, N. (Primary Chief Investigator (PCI)), McNeil, J. (Chief Investigator (CI)), Millar, J. (Chief Investigator (CI)) & Evans, S. (Primary Chief Investigator (PCI))
Trustee for For The Movember Foundation (trading as Movember Foundation)
1/03/14 → 30/06/25
Project: Research
-
Australian Prostate Cancer Clinical Registry - Jurisdictional sites
Evans, S. (Primary Chief Investigator (PCI)), McNeil, J. (Chief Investigator (CI)) & Millar, J. (Chief Investigator (CI))
Trustee for For The Movember Foundation (trading as Movember Foundation), Southern Adelaide Local Health Network Incorporated (South Australia), Cancer Institute NSW (New South Wales), Queensland University of Technology (QUT), Department of Health (Tasmania), Department of Health and Aged Care (Australia), Northern Territory Government
1/03/14 → 30/06/25
Project: Research
-
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)
Zalcberg, J. (Primary Chief Investigator (PCI)), Papa, N. (Chief Investigator (CI)), Davis, I. (Chief Investigator (CI)) & Evans, S. (Associate Investigator (AI))
10/01/17 → 31/12/22
Project: Research